The protein product of the CHI3L1 gene, human cartilage 39 kD glycoprotein (HC-gp39) is a tissuerestricted, chitin-binding lectin and member of the glycosyl hydrolase family 18. In contrast to many other monocyte/macrophage markers, its expression is absent in monocytes and strongly induced during late stages of human macrophage differentiation. To gain insights into the molecular mechanisms underlying its cell type-restricted and maturation-associated expression in macrophages, we initiated a detailed study of the proximal HC-gp39 promoter. Deletion analysis of reporter constructs in macrophage-like THP-1 cells localized a region directing high levels of macrophage-specific reporter gene expression to approximately 300 bp adjacent to the major transcriptional start site. The promoter sequence contained consensus binding sites for several known factors and specific binding of nuclear PU.1, Sp1, Sp3, USF, AML-1 and C/EBP proteins was detectable in gelshift assays. In vivo footprinting assays with DMS demonstrate that the protection of corresponding sequences was enhanced in macrophages compared to monocytes. Mutational analysis of transcription factor binding sites indicated a predominant role for a single Sp1-binding site in regulating HC-gp39 promoter activity. In addition, gelshift assays using nuclear extracts of monocytes and macrophages demonstrated that the binding of nuclear Sp1, but not Sp3, markedly increases during macrophage differentiation. Our results further highlight the important role of Sp1 in macrophage gene regulation.
INTRODUCTION
Human blood monocytes are able to differentiate into morphologically and functionally heterogeneous effector cells, including macrophages, myeloid dendritic cells, and osteoclasts (1) . In contrast to the differentiation of precursor cells this development generally proceeds in the absence of proliferation.
In myelomonocytic cell-types, several transcription factors have been identified that are important for lineage commitment, subsequent differentiation and cell type-specific gene regulation. These include members of the Ets-, C/EBP-, CBF-families and several other transcription factors (2;3). In particular the Ets family transcription factor PU.1 is essential for normal monocyte/macrophage differentiation and cell type-specific gene expression (4) (5) (6) . The defect of PU.1-/-hematopoietic progenitors may be attributed to their failure to express the receptors for macrophage colony stimulating factor (M-CSF), granulocyte (G)-CSF and GM-CSF which are critical for progenitor cell survival and proliferation (7) . PU.1 is also directly involved in the regulation of a large number of genes that are associated with myeloid and particularly with monocytic differentiation, including e.g. PU.1 itself (8), CD11b (9), CD18 (10), FcγRI (11) , FcγRIII (12) , c-fes (13) , macrophage scavenger receptor (14) , TFEC (15) , or Toll-like receptor 4 (16) .
The acquisition of a mature macrophage phenotype is clearly distinct from monocytic lineage commitment and requires expression of a new set of genes. Also, most 'macrophage-specific' marker genes that have been studied previously are already expressed in peripheral blood monocytes. To gain insight into the molecular mechanisms of macrophage differentiation, we identified a number of genes that are specifically up-regulated during the differentiation of human blood monocytes into macrophages (17) . Due to its unique cell-type restricted and maturation-associated expression, the gene CHI3L1 was chosen as a model to investigate late transcriptional events during macrophage differentiation. 4 cartilage of rheumatoid arthritis patients (18;21) in various inflammatory disorders (22) , in the liver of patients with alcoholic cirrhosis (23) , in serum of patients with recurrent breast cancer (24) and colorectal cancer (25) , and in macrophages in the atherosclerotic plaque (26) . The described expression pattern suggests a putative role in inflammation, tissue remodeling and tumor metastasis. More recently, HCgp39 was shown to stimulate proliferation of human connective-tissue cells and to activate both extracellular signal-regulated kinase-and protein kinase B-mediated signaling pathways, indicating a role as growth factor (27).
The expression of HC-gp39 is restricted to a small number of cell types (chondrocytes (18) , synovial cells (18) , neutrophils (28) and macrophages (17) ) and shows a strict correlation with late macrophage differentiation in vitro -expression is undetectable in monocytes and only marginally in monocytederived dendritic cells (17) . To approach the molecular mechanisms of gene expression during late stages of macrophage differentiation, we analyzed the expression of the gene for HC-gp39 (CHI3L1) at the transcriptional level. We cloned and sequenced the CHI3L1 gene (29) and initiated a detailed characterization of its macrophage-specific promoter. Several cis-elements important for HC-gp39 promoter activity in macrophages were defined and shown to bind Sp1-, C/EBP-, ETS-and CBF-family transcription factors in vitro. Interestingly, binding sites for tissue restricted transcription factors were largely dispensable for promoter reporter activity in THP-1 macrophages. Instead, a central role for Sp1 family factors was established in regulating HC-gp39 promoter activity. 
MATERIALS AND METHODS
Chemicals. All chemical reagents used were purchased from Sigma-Aldrich (Berlin, Germany) unless otherwise noted. Protease inhibitors are from Roche Biochemicals. Oligonucleotides were synthesized by TIB Molbiol (Berlin, Germany). Antisera for supershift analyses were purchased from Santa Cruz.
Cells.
Peripheral blood mononuclear cells (MNC) were separated by leukapheresis of healthy donors, followed by density gradient centrifugation over Ficoll/Hypaque. MO were isolated from MNC by countercurrent centrifugal elutriation in a J6M-E centrifuge (Beckman, München, Germany) as previously described (17) . MO were > 85 % pure as determined by morphology and expression of CD14 antigen. RNA-preparation and Northern analysis. Total RNA was isolated from different cell lines by the guanidine thiocyanate/acid phenol method (30) . Electrophoresis, Northern blotting and cDNA hybridization were carried out as described previously (17) . A 1200 bp cDNA of the coding region was used as HC-gp39-specific probe.
Gene cloning, plasmid construction and purification. A genomic library constructed in λFIXII (Stratagene) was screened with a 1.3 kb probe corresponding to the proximal promoter region of HCgp39 (HC-1300) that was previously generated using Promoter Walking PCR (29) . Two genomic clones covering the 5'-region of the CHI3L1 gene were identified by Southern analysis and gene specific PCR.
From one of these clones, a 1.0 kB fragment of the proximal promoter was amplified using the Expand Unidirectional deletions of the HC-1023 construct were generated using the Nested deletion Kit (Pharmacia). Subclones generated in steps of about 50-150 nucleotides were sequenced and used in reporter analysis. The HC-377 plasmid was generated by PCR using the primer HC377S and HC1AS.
Mutation of individual binding sites and construction of chimeric constructs and constructs with specific internal deletions was done by PCR-mediated mutagenesis using primers in Supporting Table 2 . PCRfragments with correctly introduced alterations were subcloned back into the corresponding wild-type plasmid. Drosophila expression plasmids for human Sp1-family proteins were a gift from Dr. G. Suske.
For transient transfections, plasmids were isolated and purified using the EndoFree Plasmid Kit from Qiagen.
DMS in vivo footprinting.
Genomic footprining was performed essentially as described (31) . For each footprint reaction 10 7 cells were harvested, washed with phosphate buffered saline (PBS), resuspended in 1 ml of PBS, and incubated at room temperature for 1 minute with 5 µl of dimethyl sulfate. The reaction was stopped by the addition of 5 ml DMS stop solution containing 1% bovine serum albumin and 100µM β-mercaptoethanol in PBS. Cells were washed once more in DMS stop solution and twice more with PBS. Finally, cells were resuspended in 1 ml of PBS and genomic DNA was prepared. Footprinted DNAs were subjected to piperidine treatment (32) . For visualization of footprints by LMPCR, 2 µg of sequenced or footprinted DNA were analyzed as described (33;34) with modifications (31). The primers for LMPCR are listed in Supporting Schneider cells were cells were cotransfected using 10 µl Effectene reagent and 1.5 µg total DNA (1 µg of reporter plasmid, 0.5 µg of individual expression plasmids). Duplicate transfections were harvested after 48h and cell lysates assayed for firefly luciferase activity using the Luciferase Reporter Assay System (Promega). Firefly luciferase activity of individual transfections was normalized against protein concentration measured using a BCA assay (Sigma).
Nuclear extracts and electrophoretic mobility shift assay. Nuclear extracts from HeLa cells, THP-1 or in vitro differentiated human macrophages were prepared using NP-40 lysis as described (15) . Nuclear extracts from freshly isolated human monocytes were prepared using identical buffers except that nuclei were released without detergent by shearing with 15-20 passages through a 26-gauge needle mounted in a 1 ml syringe. All buffers used contained 1 mM Na 3 VO 4 and a cocktail of protease inhibitors (2 µg/ml aprotinin, 0.5 µg/ml leupeptin, 1 µg/ml pepstatin, 20 µg/ml bestatin, 5 µg/ml E46, 50 µg/ml antipain, 100 µg/ml chymostatin). Oligonucleotides were end-labeled with [γ 32 P]-ATP using T4 polynucleotide kinase or with α-[ 32 P]dNTP using Klenow DNA polymerase. The binding reaction contained 2.5 µg of nuclear extract protein or 0.5 -2 µl of the in vitro translation reaction, 0.5 µg of poly d(I/C), 20 mM HEPES pH 7.9, 60 mM KCl, 1mM DTT, 1mM EDTA, pH 8.0, 5% glycerol and 20 nmol of probe DNA in a final volume of 10 µl. Antisera used in supershift analyses were added after 15 min and samples were loaded onto polyacrylamide gels after standing at room temperature for a total of 30 min. Buffers and running conditions used have been described (15) . Gels were fixed in 5% acetic acid, dried and autoradiographed. Tissue specific reporter activity of the 5'-proximal HC-gp39 promoter. To test whether the HC-gp39
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promoter could confer cell type-specific activity in reporter assays, we cloned a 1.0 kb fragment of the 5'-proximal promoter region of the human CHI3L1 gene into a luciferase reporter plasmid (HC-1023).
Transient transfection analysis was performed in the myeloid cell lines THP-1 and U937, and two nonmyeloid cell lines, Mel Im (melanoma) and HeLa (cervical carcinoma), which do not express HC-gp39 mRNA (data not shown). Luciferase activities were normalized for transfection efficiency by cotransfection with a renilla construct and results for individual cell lines were compared relative to the activity of a positive control (a CMV-driven luciferase construct). As shown in Table 1 , strong reporter activity was detectable only in THP-1 cells, which is consistent with endogenous HC-gp39 expression in this cell line. Similar results were obtained using a shorter (377 bp) fragment of the proximal promoter (s. Table 1 ).
Deletion analysis of the 5'-flanking HC-gp39 sequence region. To narrow down regions that are important for HC-gp39 promoter activity in macrophages, multiple deletion constructs were generated. λ- Structure of the proximal HC-gp39 promoter. The initial deletion analysis localized a region directing strong macrophage specific reporter gene expression to approximately 300 bp proximal to the major transcriptional start site that was determined by primer extension in a previous study (29) . In contrast to many other myeloid-specific genes the HC-gp39 promoter contains a TATA-box and a TATA-like CATA-element, both approximately 30 bp upstream of the two transcriptional initiation sites (sequence is shown in Supporting Figure 10 ). Within the proximal promoter region, several putative binding sites for ubiquitous transcription factors (Sp1, AP-1, AP-2, basic helix-loop-helix) and tissue restricted factors (e.g. C/EBP, AML-1) were identified by computer analysis using the MatInspector database (Genomatix).
In addition we identified several purine-rich elements that might be bound by members of the Ets-family, including the myeloid and B-cell-specific transcription factor PU.1. To compare human and murine promoters, the corresponding promoter region of the putative mouse homologue brp39 was cloned.
Sequence comparison with the human HC-gp39 promoter revealed a marked degree of conservation between the species man and mouse (Supporting Figure 10 ). However, strong decreases in reporter activity were observed after deletion of the putative Sp1 (S) sequence and a putative binding site for bHLH-ZIP (B) transcription factors. Internal deletions were generated within the HC-377 construct which covered three sets of neighboring putative binding sites.
Deletion of the putative C/EBP-AML-1 region (HC-377_ExAC construct) resulted in the loss of about 20% reporter activity, removal of the Sp1-bHLH-ZIP region (HC-377_ExSB construct) showed approximately 50 % decreased reporter activity and deletion of the region between CATA and TATA box (HC-377_ExZT construct) had no impact on the reporter activity ( Figure 3B ). Transcription factor binding to the proximal HC-gp39 promoter. Gelshift experiments were performed to identify transcription factors that bind sequence elements determined by in vivo footprinting or consensus site analysis. As the importance of PU.1 recognition motifs for tissue-restricted expression of myeloid genes has been demonstrated in a growing number of cases, we tested the ability of PU.1 to bind elements within the human HC-gp39 promoter. EMSA was performed with double stranded oligonucleotides corresponding to two sequences containing a 5'-GGAA-3' core sequence (hc-PU, and hc-Ets). Figure 5A and 5B show EMSAs using either in vitro translated PU.1 or nuclear extracts of THP-by the addition of an excess amount of unlabelled wild-type oligonucleotide, but not by oligonucleotides with a mutated 5'-GGAA-3' core sequence. Also, formation of both complexes was hindered in the presence of a PU.1-specific antiserum. In contrast to the hc-PU oligonucleotide which preferentially bound PU.1, several additional specific bands where detected using the hc-Ets oligonucleotide. Several antisera against possible binding proteins (STAT1, -3, and 5 as well as SRF) were used for super shift experiments -none of them altered the observed band pattern (data not shown).
DNA-protein interactions in
The central region containing the putative Sp1 (-206) and bHLH (-187) factor binding sites were also analyzed using EMSA. As shown in Figure 5C , using cold competition and supershift analysis, complexes containing Sp1, Sp3, USF1 and USF2a were detectable, including high mobility complexes containing factors from both families. A C/EBP-AML1 motif (-240 and -247) also represented a good candidate region for myeloid specific gene regulation. EMSAs and supershift experiments performed with a corresponding double stranded oligonucleotide identified three specific complexes in THP-1 nuclear extracts containing either AML1, C/EBPα or both factors (s Figure 5D Mutational analysis of transcription factor binding sites. Site-specific mutations at putative transcription factor binding sites were introduced into the HC-377 construct to determine the importance of individual sites for promoter activity in transfection assays. As shown in Figure 6 the activity of the proximal promoter in THP-1 cells was not completely abolished after mutation of any single binding site, which is consistent with the results obtained with internal deletion constructs (see Figure 3) . Mutation of the central Sp1-binding site caused the greatest reduction of reporter activity to 50%. The mutated C/EBP site caused a 30% loss of reporter activity, whereas several other mutations reduced activity around 10-20%. The presence of an intact AML-1 site was not required for full reporter activity in THP-1 cells. In constructs bearing two or more mutations, the effects of individual mutations were mostly additive. After mutation of both the central Sp1 and the C/EBP site only 20% of the wild-type reporter activity was left.
The presence of two TATA-like sequences as well as multiple binding sites probably allows alternative arrangements of transcription factor complexes, still resulting in relatively strong reporter activity in THP-1 cells. Minimal constructs were generated lacking the region between CATA and TATA box and sequences upstream of the AML-1 site, reducing the proximal promoter to fewer binding sites and only one TATA-box to initiate transcription. As shown in Figure 6 , luciferase activity of the minimal construct was similar to the wild-type construct. Mutation of the central Sp1-site had a markedly higher impact on reporter activity, further demonstrating the importance of this cis-element for HC-gp39 promoter activity. 
Analysis of elements required for
DISCUSSION
In the present study, we characterize the transcriptional regulation of human cartilage gp39 (HC-gp39) during macrophage differentiation. We describe a functional analysis of the proximal HC-gp39 promoter region and the identification of cis-elements and trans-acting factors that are important for the specific expression of HC-gp39 in macrophages.
In contrast to the differentiation process of myeloid precursor cells, differentiation of human blood monocytes in vitro and in vivo is typically not accompanied by proliferation. Since a number of regulatory mechanisms controlling differentiation are believed to require cell division, other mechanisms must operate during the differentiation of monocytes to achieve the functional and morphological heterogeneity of the terminally differentiated cells which include the various types of tissue macrophages, osteoclasts and myeloid dendritic cells. However, not much is known about the factors and mechanisms controlling gene expression during terminal monocyte differentiation. To gain insight into the regulatory mechanisms during this process it is necessary to study highly regulated model genes.
We have previously isolated a number of genes that are strongly up-regulated during macrophage differentiation (17) . Among those, the CHI3L1 gene encoding the glycoprotein HC-gp39 appeared to be an ideal model gene to study transcription regulation during monocyte differentiation. HC-gp39 mRNA is undetectably low in peripheral blood monocytes and highly induced during in vitro differentiation of macrophages (17) . As a starting point to unveil the molecular mechanisms behind its macrophagerestricted expression pattern, we cloned and analyzed the proximal promoter of the CHI3L1 gene. The proximal promoter was sufficient to confer cell-type specific reporter activity in a human macrophage cell line (THP-1) which was also found to express high endogenous levels of HC-gp39 mRNA. Levels of HC- with each other and with other factors (44) (45) (46) (47) (48) (49) . Further investigations will be needed to clarify these issues.
In conclusion, we have presented a thorough analysis of promoter elements controlling the expression of HC-gp39, a marker for late stages of macrophage differentiation. Our findings suggest that the ubiquitous transcription factor Sp1 is markedly up-regulated during monocyte to macrophage differentiation and is an important regulator of HC-gp39 and likely of other genes with a maturation-associated expression pattern in macrophages. 
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